Advanced PET Imaging, Nuclear Medicine, and Therapy: From Diagnostics to Theranostics

Memo

This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging and Nuclear Medicine therapy will be presented.At the conclusion of this course, participants will be able to:- Describe new developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging and therapy with specific focus on DOTA, PSMA, and PRRT- Describe the logistics of bringing these new diagnostic and therapeutic technologies to clinical practice- Identify the key clinical indications for new emerging tracers for Neuroendocrine Tumor and Prostate cancer using somatostatin receptor and PSMA PET/CT imaging- Review and discuss the standard-of-care clinical application and advanced interpretation of FDG PET/CT URLs:Tickets: https://go.evvnt.com/3312323-2?pid=5569Virtual: https://go.evvnt.com/3312323-3?pid=5569 Date and Time: Wednesday, 22 October 2025 at 07:30 - Thursday, 23 October 2025 at 16:45 Venue details: Online Category: Conferences | Science, Health and Medicine | CME (Continuing Medical Education) Prices:Standard Registration-Physicians MD/DO : USD 1495.00,Nurses/Advanced Practice Professionals/Retired/Active Military : USD 1395.00,Radiologic Technologists/Residents/Fellows : USD 1295.00 Speakers: Phillip Kuo, MD, PhD, FACR, Don C. Yoo, MD